Literature DB >> 16922639

Expression and function of multidrug resistance transporters at the blood-brain barriers.

Jean-Michel Scherrmann1.   

Abstract

The presence of active carrier-mediated transport of substrates from the brain to the blood is a major feature of the barrier properties of the blood-brain barrier (BBB). These proteins lie in the luminal or abluminal membranes of the endothelial cells that form the BBB. Some are ATP-binding cassette proteins (ABC) and many amphipathic cationic drugs are carried by P-glycoprotein (ABCB1) or ABCG2, which lie at the luminal pole of the BBB. Several multidrug resistance-associated proteins (MRPs, ABCCs) are also present on the membranes of brain microvessels; these are mainly involved in the efflux of anionic compounds. All these ABC proteins help to protect the brain and form a critical target for CNS pharmaceuticals, influencing the clinical variability of responses to, and the design of, these drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16922639     DOI: 10.1517/17425255.1.2.233

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  16 in total

Review 1.  Blood-Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies.

Authors:  Loqman A Mohamed; Shashirekha Markandaiah; Silvia Bonanno; Piera Pasinelli; Davide Trotti
Journal:  AAPS J       Date:  2017-08-04       Impact factor: 4.009

Review 2.  ABCG transporters and disease.

Authors:  Owen M Woodward; Anna Köttgen; Michael Köttgen
Journal:  FEBS J       Date:  2011-06-13       Impact factor: 5.542

3.  Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4) in the Active Efflux of Anionic Drugs Across the Blood-Brain Barrier.

Authors:  Kayoko Kanamitsu; Hiroyuki Kusuhara; John D Schuetz; Kenji Takeuchi; Yuichi Sugiyama
Journal:  J Pharm Sci       Date:  2017-04-27       Impact factor: 3.534

4.  Response of the ABCG2 promoter in T47D cells and BeWo cells to sex hormone treatment.

Authors:  Satoru Yasuda; Masaki Kobayashi; Shirou Itagaki; Takeshi Hirano; Ken Iseki
Journal:  Mol Biol Rep       Date:  2008-11-08       Impact factor: 2.316

5.  MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells.

Authors:  Mark Eilers; Upal Roy; Debasis Mondal
Journal:  Exp Biol Med (Maywood)       Date:  2008-06-05

Review 6.  Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy.

Authors:  Kathleen Köck; Markus Grube; Gabriele Jedlitschky; Lena Oevermann; Werner Siegmund; Christoph A Ritter; Heyo K Kroemer
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 7.  Glutathione metabolism and Parkinson's disease.

Authors:  Michelle Smeyne; Richard Jay Smeyne
Journal:  Free Radic Biol Med       Date:  2013-05-08       Impact factor: 7.376

8.  Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties.

Authors:  Marianne Seleman; Hélène Chapy; Salvatore Cisternino; Cindie Courtin; Maria Smirnova; Joël Schlatter; Fouad Chiadmi; Jean-Michel Scherrmann; Florence Noble; Cynthia Marie-Claire
Journal:  Psychopharmacology (Berl)       Date:  2014-04-05       Impact factor: 4.530

Review 9.  On the rate and extent of drug delivery to the brain.

Authors:  Margareta Hammarlund-Udenaes; Markus Fridén; Stina Syvänen; Anubha Gupta
Journal:  Pharm Res       Date:  2007-12-05       Impact factor: 4.200

10.  Brain endothelial cell-cell junctions: how to "open" the blood brain barrier.

Authors:  Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.